Neurovascular Stents

Neurovascular Stents

Global Neurovascular Stents Market to Reach US$3.4 Billion by 2030

The global market for Neurovascular Stents estimated at US$1.8 Billion in the year 2023, is expected to reach US$3.4 Billion by 2030, growing at a CAGR of 9.6% over the analysis period 2023-2030. Carotid Artery Stents, one of the segments analyzed in the report, is expected to record a 10.3% CAGR and reach US$2.5 Billion by the end of the analysis period. Growth in the Intracranial Stents segment is estimated at 8.0% CAGR over the analysis period.

The U.S. Market is Estimated at US$492.8 Million While China is Forecast to Grow at 8.9% CAGR

The Neurovascular Stents market in the U.S. is estimated at US$492.8 Million in the year 2023. China, the world`s second largest economy, is forecast to reach a projected market size of US$511.5 Million by the year 2030 trailing a CAGR of 8.9% over the analysis period 2023-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 8.7% and 7.8% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 7.6% CAGR.

Global Neurovascular Stents Market - Key Trends & Drivers Summarized

What Are Neurovascular Stents and Why Are They Crucial in Stroke Management?
Neurovascular stents are specialized devices used to treat cerebrovascular conditions, particularly in the prevention and treatment of ischemic strokes and aneurysms. These small, mesh-like tubes are implanted in blood vessels in the brain to help keep arteries open or to redirect blood flow away from aneurysms. In cases of ischemic stroke, where blood clots block the flow of blood to the brain, neurovascular stents are often deployed to restore circulation and prevent permanent brain damage. For aneurysms, flow-diverting stents offer an effective way to redirect blood away from weakened vessel walls, reducing the risk of rupture.

Neurovascular stents are vital because they enable minimally invasive treatments for conditions that would otherwise require more invasive and higher-risk procedures. Their ability to support the artery walls and prevent collapse during and after the procedure is critical to their effectiveness. The use of these stents has revolutionized stroke management by improving patient outcomes, reducing recovery times, and significantly decreasing the risk of recurrent strokes or aneurysm ruptures.

How Is the Neurovascular Stents Market Advancing?
The neurovascular stents market is advancing quickly due to the development of more sophisticated and specialized stent designs. One of the key trends is the rise of flow-diverting stents, which are becoming increasingly popular for treating complex and wide-necked aneurysms. Unlike traditional stents, flow-diverters work by diverting blood flow away from the aneurysm, allowing the vessel to heal over time. This innovation reduces the need for multiple procedures and offers a safer alternative for aneurysms that were once considered inoperable.

Another significant advancement is in the development of self-expanding stents, which are designed to conform to the unique shape of the patient’s blood vessel. These stents can be deployed with greater precision and are less likely to cause trauma to the artery. Moreover, bioresorbable stents, which gradually dissolve after serving their purpose, are gaining traction. These stents reduce the long-term risks associated with permanent implants and are particularly beneficial in younger patients or those at higher risk for complications from traditional metal stents.

Which Conditions Are Driving the Adoption of Neurovascular Stents?
The adoption of neurovascular stents is primarily driven by the need to treat ischemic strokes and brain aneurysms. In ischemic strokes, where a blood clot obstructs blood flow to the brain, stent retrievers are critical in restoring circulation and preventing long-term disability or death. These devices allow for the mechanical removal of the clot and the reopening of the blocked artery, significantly improving patient outcomes. Neurovascular stents are also used in the treatment of carotid artery stenosis, a condition in which the carotid arteries narrow and restrict blood flow to the brain, increasing stroke risk.

Brain aneurysms are another key condition driving stent adoption. Flow-diverting stents are used to treat wide-necked or large aneurysms that are difficult to treat with traditional coiling techniques. These stents offer a minimally invasive solution that reduces the risk of aneurysm rupture and allows for vessel healing over time. Additionally, neurovascular stents are being used in treating vascular malformations such as arteriovenous malformations (AVMs), further expanding their applications in neurology.

What Are the Key Growth Drivers in the Neurovascular Stents Market?
The growth in the neurovascular stents market is driven by several factors. The increasing incidence of ischemic strokes and brain aneurysms, particularly among aging populations, is a primary driver of demand. Additionally, the growing preference for minimally invasive procedures is pushing the adoption of neurovascular stents, as they offer safer, faster, and more effective treatment options than traditional surgery. Technological innovations in stent design, such as flow-diversion technology and bioresorbable materials, are also fueling market growth by improving the safety and efficacy of these devices.

The rising awareness of stroke prevention and the benefits of early intervention, along with government initiatives to reduce stroke-related mortality, are further boosting the market. Moreover, advances in medical imaging and real-time navigation technologies are making neurovascular stent procedures more precise, enhancing patient outcomes. Expanding healthcare infrastructure in developing regions is also contributing to market growth by increasing access to advanced neurovascular treatments.

Select Competitors (Total 11 Featured) -

• Abbott Laboratories
• ACANDIS GmbH
• Blockade Medical LLC
• Cordis Corporation
• InspireMD, Inc.
• Medtronic PLC
• MicroPort Scientific Corporation
• STI Laser Industries, Ltd.
• Stryker Corporation
• Terumo Medical Corporation
• W. L. Gore & Associates

Please note: Reports are sold as single-site single-user licenses. Electronic versions require 24-48 hours as each copy is customized to the client with digital controls and custom watermarks. The Publisher uses digital controls protecting against copying and printing is restricted to one full copy to be used at the same location.

The latest version of Adobe Acrobat Reader is required to view the report. Upon ordering an electronic version, the Publisher will provide a link to download the purchased report.

Prior to fulfillment of an order, the client will be required to sign a document detailing the purchase terms for a publication from this publisher.